Back
Editas Medicine Vs. Avidity Biosciences Industry Stock Comparison
Sell
49
EDIT
Editas Medicine
Last Price:
$2.76
Seasonality Move:
-16.27%
Sell
40
RNA
Avidity Biosciences
Last Price:
$33.80
Seasonality Move:
-9.57%
Sell
49
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $2.76. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $33.76. The Score for RNA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $2.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $33.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 60.23 | Buy |
Chaikin Money Flow: | -120810 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.15 - 2.81) | Buy |
Bollinger Bands (100): | (1.26 - 2.26) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.24 | Buy |
Relative Strength Index (14 RSI): | 61.58 | Buy |
Chaikin Money Flow: | -1781609 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.8 - 32.26) | Buy |
Bollinger Bands (100): | (27.85 - 32.67) | Buy |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.87 | Sell |
20-day SMA: | 2.55 | Buy |
50-day SMA: | 2.07 | Buy |
200-day SMA: | 1.98 | Buy |
8-day EMA: | 2.52 | Buy |
20-day EMA: | 1.69 | Buy |
50-day EMA: | 0.86 | Buy |
200-day EMA: | 0.25 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.6 | Buy |
20-day SMA: | 30.57 | Buy |
50-day SMA: | 30.85 | Buy |
200-day SMA: | 34.32 | Sell |
8-day EMA: | 29.54 | Buy |
20-day EMA: | 19.33 | Buy |
50-day EMA: | 9.78 | Buy |
200-day EMA: | 2.78 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.08 per share, an increase this year of $0.82 per share, and an increase next year of $0.69 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.09 per share, and a decrease next year of $0.45 per share.
Editas Medicine Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |